Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

Five-year exploratory follow-up analysis of KEYNOTE-671 continued to show clinically meaningful improvements in overall survival and event-free survival with KEYTRUDA plus chemotherapy before surgery, ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. The key? Detecting tiny lung nodules when doctors ...

First and only systemic therapy to improve survival when used before and after surgery for patients with MIBC who are ineligible for cisplatin-based chemotherapy First ever positive Phase 3 study in ...

TORONTO — Five-year survival rates for people with lung cancer have doubled since the 1990s, but the disease still kills more patients than any other type of cancer, a Statistics Canada report said on ...